OS-070 Achieving undetectable hepatitis delta virus RNA at end of therapy with bulevirtide 10 mg/day with or without with pegylated interferon alpha is strongly associated with post-treatment virologic response in chronic hepatitis delta

IF 26.8 1区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY

Journal of Hepatology Pub Date : 2025-05-01 DOI:10.1016/S0168-8278(25)00385-X

Fabien Zoulim, Tarik Asselah, Soo Aleman, Maurizia Brunetto, Vladimir Chulanov, Adrian Streinu-Cercel, George Sebastian Gherlan, Pavel Bogomolov, Tatiana Stepanova, Viacheslav Morozov, Olga Sagalova, Renee-Claude Mercier, Lei Ye, Amos Lichtman, Dmitry Manuilov, Heiner Wedemeyer, Pietro Lampertico

引用次数: 0

查看原文本刊更多论文

在慢性丁型肝炎治疗结束时，使用布来韦肽（10mg /天）联合或不联合聚乙二醇化干扰素治疗，丁型肝炎病毒RNA检测不到与治疗后的病毒学反应密切相关

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Hepatology 医学-胃肠肝病学

CiteScore

46.10

自引率

4.30%

发文量

2325

审稿时长

30 days

期刊介绍： The Journal of Hepatology is the official publication of the European Association for the Study of the Liver (EASL). It is dedicated to presenting clinical and basic research in the field of hepatology through original papers, reviews, case reports, and letters to the Editor. The Journal is published in English and may consider supplements that pass an editorial review.